Camargo
JUNE 3, 2020
Oncology patients face a difficult journey — a frightening diagnosis followed by intricate and oftentimes. The post Patient-Centered Drug Development for Oncology Products appeared first on Camargo.
Triage Cancer
JUNE 5, 2020
Get the latest legal information for individuals diagnosed with cancer and their caregivers. As states begin to reopen and employees are asked to return to work, many people with a cancer diagnosis, and their caregivers, are questioning what options they have. What is available to you may depend on whether you are an individual diagnosed with cancer and concerned about how a compromised immune system can increase your risk of getting COVID-19, or if you are a caregiver concerned about exposing y
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
JUNE 4, 2020
Marketing is challenging in these days of COVID-19 because each person and business is experiencing the virus in different ways. All are impacted and all are (trying) to adapt. Some are suffering, some are growing. Regardless of if you’re suffering or growing right now, you’re likely anxious and fearful about what will come next, and likely feeling more isolated than ever before, even if you’re more engaged than others.
Pharmacy Checkers
JUNE 4, 2020
Using very similar talking points to Big Pharma-funded experts , in its quest to “educate” the public about the dangers of internet pharmacies and personal medicine imports, the National Association of Boards of Pharmacy (NABP) appears to have ignored the greatest pharmacy-related public health travesty happening right under its nose. Since the beginning of this century, billions of prescription opioid pills were wrongly, and in many cases unlawfully, pushed on and distributed to Americans.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Cloudbyz
JUNE 2, 2020
Open reports with a click of a button and dynamically pass parameters to report filters! Purpose: This blog will show you how to create dynamic contextual reports that users can access directly from the record, (ie: Account or Opportunity). Instead of having to navigate to the Reports tab, search for your report, and add the record as a filter, the same can be achieved straight from the record page.
JAMA Internal Medicine
MAY 31, 2020
This Viewpoint emphasizes the importance of mitigating the mental health consequences of social distancing in the COVID-19 era.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
My Local Study
JUNE 1, 2020
“There are decades where nothing happens, and there are weeks where decades happen.” Each day that passes us, there’s new information released about COVID-19 and humanity’s efforts to tackle this global pandemic. The constant updates are enough to make your head spin; so, here’s what you need to know right now. What’s New With COVID-19?
Cloudbyz
JUNE 4, 2020
The whole world is working from home now and is going to do so throughout the year. We need to gear up for this situation and find lasting solutions. The five reasons why working from home involves working more and being less productive. The approaches to relieve the challenges and progress towards better performance are listed below. Connected. Always being connected to the team leads to multiple virtual meetings and drains away the time and energy of everyone.
Forte Research Systems®
JUNE 2, 2020
For much of 2020, COVID-19 has challenged "normal," daily lives of many, but what does that mean for clinical research?
Pharma Tutor
JUNE 5, 2020
ABOUT AUTHORS 1 Kanishk Kala, 2 Dr Rupinder Kaur Sodhi 1 Research Scholar Pharmacy Chandigarh College of Pharmacy IK Gujral PTU Punjab 2 Guide Pharmacology Chandigarh College of Pharmacy IK Gujral PTU Punjab. ABSTRACT. At present time COVID-19 has become a global threat. In spite of modern technology The medical management of the said disease is not yet accomplished.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma in Brief
JUNE 4, 2020
This week has seen a number of developments relating to the Patented Medicine Prices Review Board ( PMPRB ), including a six-month delay to the implementation of amendments to the Patented Medicines Regulations and renewed consultation by the Board on revised Draft Guidelines to implement those amendments. Meanwhile, the Federal Court is now considering a judicial review of those amendments.
Drug Channels
JUNE 1, 2020
Like many of you, I was disappointed that Asembia had to cancel its 2020 Specialty Pharmacy Summit. As a small consolation, Asembia is providing a series of on-demand business sessions. You can view them for FREE if your registration to the 2020 Specialty Pharmacy Summit was transferred to the 2021 Summit. Everyone else will have to pay a small fee.
Drug Discovery Today
JUNE 5, 2020
India-based Sai Life Sciences sets up first European hub at Alderley Park
Pharma Tutor
JUNE 4, 2020
ABOUT AUTHORS : Disha Chouhana*1, Dr. Rajesh Mujariya2. 1*Department of Pharmaceutical Chemistry, School of Pharmaceutical Science and Research , Balaghat, Madhya Pradesh, India. 2Department of Pharmaceutics, School of Pharmaceutical Science and Research , Balaghat, Madhya Pradesh, India. rajeshmujariya@gmail.com. ABSTRACT : There is a new public health crises threatening the world with the emergence and spread of 2019 novel corona virus (2019-nCoV) or the severe acute respiratory syndrome coro
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharma in Brief
JUNE 2, 2020
The Federal Court of Appeal ( FCA ) and the Federal Court ( FC ) have extended their Suspension Periods to June 15, 2020. Federal Court of Appeal. On May 28, 2020, the FCA issued a Notice to the Parties and the Profession extending the Suspension Period to June 15, 2020. Federal Court. On May 29, 2020, the FC issued an updated Practice Direction and Order ( FC Update ), also extending the Suspension Period to June 15, 2020.
Pharma Packaging Solutions
JUNE 4, 2020
In the May issue of Tablets and Capsules, our own Scott Garverick, weighs in on the cover topic – “Packaging Sustainability.” The money quote from Scott is “We ensure that our waste paperboard is recycled into print media, packaging, and folding carton stock… Also, we have led a number of companies from 3-ply corrugated materials to single-sheet substrates as a component of our green packaging initiative.” We are sharing the article below and you can also link
Drug Discovery Today
JUNE 3, 2020
Financing led by Seroba Life Sciences.
Pharma Tutor
JUNE 3, 2020
CHAURASIYA AMRITA*, ARORA RIMJHIM, RATHORE KS, CHUNDAWAT AVS . Faculty of Pharmacy, BN University, Udaipur- Raj.313001 rimjhim.arora30@gmail.com*. ABSTRACT. Six Sigma is a highly disciplined activity that focuses on growing and giving near perfect product and services. Six Sigma focuses what is important to customer. It reduces defects in process variation so that virtually all the products or services provided meet customer expectations.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma in Brief
JUNE 1, 2020
The Federal Court has dismissed two infringement actions brought against defendants under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations ( Regulations ), following a common trial on the validity of Canadian Patent No. 2,562,277 ( 277 Patent ). The Court found that all the asserted claims – to uses for treating multiple sclerosis ( MS ) – were obvious and that some were anticipated.
Expert insights. Personalized for you.
130 
Let's personalize your content